Beijing Wantai Biological Pharmacy Enterprise (SHA:603392) subsidiary Wantai Canghai has submitted a prequalification application with the World Health Organization for its nine-valent human papillomavirus (HPV) vaccine, according to a Tuesday filing with the Shanghai bourse.
Shares of the drugmaker declined 2% in recent trade.